Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Temporal Trends in Relative Survival of Diffuse Large B-Cell Lymphoma in Sweden and Denmark in the Era of Targeted and Cellular Therapies: A Population-Based Binational Study

Sara Harrysson, Sandra Eloranta, Stefanie Antonilli, Mikkel Runason Simonsen, Kristina Sonnevi, Peter de Nully Brown, Bjorn E Wahlin, P-O Andersson, Judit Mészáros Joergensen, Mats Jerkeman, Christian Bjørn Poulsen, Gunilla Enblad, Tarec Christoffer El-Galaly, Karin Ekstroem Smedby

Blood (2024) 144 (Supplement 1): 654.

https://doi.org/10.1182/blood-2024-201964

Published: 2024

Journal Articles

Age-Based Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI) in a Real-World Danish Study: Suboptimal Performance in Older Patients

Rasmus Rask Kragh Jørgensen, Sandra Eloranta, Jacob Haaber Christensen, Martin Hutchings, Rasmus Bo Dahl-Soerensen, Peter Kamper, Andrew M Evens, Matthew J. Maurer, Susan K Parsons, Angie Mae Rodday, Jenica Upshaw, Tarec Christoffer Christoffer El-Galaly, Lasse Hjort Jakobsen

Blood (2023) 142 (Supplement 1): 4455.

https://doi.org/10.1182/blood-2023-178498

Published: 2023

Journal Articles

Reproduktiv Patterns Among Non-Hodgkin Lymphoma Survivors By Subtype in Sweden, Denmark and Norway

Joshua P.P. Entrop, Caroline E. Weibull, Karin E. Smedby, Lasse Hjort Jakobsen, Andreas K. Oevlisen, Ingrid Glimelius, Anna Marklund, Thomas S. Larsen, Harald Holte, Alexander Fosså, Knut B. Smeland, Tarec Christoffer Christoffer El-Galaly, Sandra Eloranta

Blood (2022) 140 (Supplement 1): 1079–1081.

https://doi.org/10.1182/blood-2022-155919

Published: 2022

Journal Articles

Treatment-Related Circulatory Diseases and Mortality in Hodgkin Lymphoma Patients Using Multi-State Modelling and Relative Survival

Joachim Baech, Lasse Hjort Jakobsen, Tarec Christoffer Christoffer El-Galaly, Daniel Molin, Ingrid Glimelius, Joshua P.P. Entrop, Michael Crowther, Karin Ekstroem Smedby, Sandra Eloranta, Caroline E. Weibull

Blood (2022) 140 (Supplement 1): 9411–9412.

https://doi.org/10.1182/blood-2022-157279

Published: 2022

Journal Articles

Risk of Incident Diabetes and Dysregulated Pre-Existing Diabetes Mellitus in Newly Diagnosed Lymphoma Patients Treated with Steroid-Containing Immunochemotherapy: A Danish Population-Based Study

Joachim Baech, Marianne Tang Severinsen, Andreas Kiesbye Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit M. Jørgensen, Michael Roost Clausen, Christian Bjørn Poulsen, Peter de Nully Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekstroem Smedby, Sandra Eloranta, Lasse H. Jakobsen, Tarec Christoffer El-Galaly

Blood (2021) 138 (Supplement 1): 454.

https://doi.org/10.1182/blood-2021-144733

Published: 2021

Journal Articles

High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients

Katharine Louise Lewis, Lasse H. Jakobsen, Diego Villa, Sabela Bobillo, Karin Ekstroem Smedby, Kerry J. Savage, Toby A. Eyre, Kate Cwynarski, Paris L Caporn, Joan Van Zyl, Magdalena Klanova, Marek Trněný, Robert Puckrin, Douglas A. Stewart, Mark J Bishton, Christopher P. Fox, Aung M Tun, Gita Thanarajasingam, Faouzi Djebbari, Erel Joffe, Sandra Eloranta, Sara Harrysson, Laurie H. Sehn, Seth M Maliske, Kittika Poonsombudlert, Xiao Guo, Greg Hapgood, Kate Manos, Eliza Hawkes, Jahanzaib Khwaja, Adrian Minson, Michael Dickinson, Andreas Kiesbye Øvlisen, Gareth P Gregory, Michael Gilbertson, Isaac T Streit, Hamish W Scott, Matthew Ku, Sanjay de Mel, Kar Ying Yong, Liu Xin, Mridula Mokoonlall, Dipti Talaulikar, Nicholas L McVilly, Anna Johnston, Matthew J Brunner, Priyanka A Pophali, Matthew J. Maurer, Tarec Christoffer El-Galaly, Chan Yoon Cheah

Blood (2021) 138 (Supplement 1): 181.

https://doi.org/10.1182/blood-2021-146737

Published: 2021

Journal Articles

Evaluation of Eligibility for CAR-T Cell Therapy in a Population-Based Cohort of 3550 Patients with Incident Diffuse Large B-Cell Lymphoma (DLBCL) in Sweden

Karin Ekstroem Smedby, Sara Harrysson, MD, Sara Ekberg, Mats Jerkeman, MD PhD, Per-Ola Andersson, MD PhD, Gunilla Enblad, Sandra Eloranta

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-138737

Published: 2020

Journal Articles

Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden

Sara Harrysson, MD, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, MD Professor, Sverker Hasselblom, Björn E Wahlin, MD PhD, Per-Ola Andersson, MD PhD, Karin E. Smedby, MD PhD

Blood (2019) 134 (Supplement_1): 399.

https://doi.org/10.1182/blood-2019-122014

Published: 2019

Journal Articles

Autologous Stem Cell Transplantation in Mantle Cell Lymphoma - Selection Mechanisms and Survival By Age Group

Ingrid Glimelius, MD PhD, Karin E. Smedby, MD PhD, Alexandra Albertsson-Lindblad, MD PhD, Sandra Eloranta, Mats Jerkeman, MD Professor, Caroline Weibull

Blood (2019) 134 (Supplement_1): 4572.

https://doi.org/10.1182/blood-2019-124676

Published: 2019

Journal Articles

Treatment Intensity, Timing of Relapse and Outcome of 713 Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Setting in Sweden

Karin Ekstrom Ekstroem Smedby, Sara Ekberg, Sandra Eloranta, Gunilla Enblad, Mats Jerkeman, MD Professor, Per-Ola Andersson, MD PhD, Sara Harrysson, MD

Blood (2019) 134 (Supplement_1): 4111.

https://doi.org/10.1182/blood-2019-123785

Published: 2019

Journal Articles

Fertility Rates in Young Hodgkin Lymphoma Survivors: A Danish Nationwide Cohort Study of 769 Patients

Andreas Kiesbye Øvlisen, MD, Lasse H. Jakobsen, PhD, Kristian Hay Kragholm, Martin Hutchings, MD PhD, Henrik Frederiksen, MD PhD Prof, Peter Kamper, Sandra Eloranta, Caroline Weibull, Ingrid Glimelius, MD PhD, Karin Ekstrom Ekstroem Smedby, Marianne Tang Severinsen, MD PhD, Tarec Christoffer C. El-Galaly, MD

Blood (2019) 134 (Supplement_1): 2841.

https://doi.org/10.1182/blood-2019-122642

Published: 2019

Journal Articles

Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Karin Ekstrom Smedby, MD PhD, Sara Harrysson, MD, Per-Ola Andersson, Gunilla Enblad, Sara Ekberg, Mats Jerkeman, Sandra Eloranta

Blood (2018) 132 (Supplement 1): 4200.

https://doi.org/10.1182/blood-2018-99-116343

Published: 2018

Journal Articles

Relapse Risk and Loss in Expectation of Lifetime in Young Classical Hodgkin Lymphoma Patients - a Nordic Lymphoma Group Study of 2,582 Patients

Jorne Lionel Biccler, MSc, BSc, Ingrid Glimelius, MD PhD, Sandra Eloranta, Knut B. Smeland, Peter de Nully Brown, MD PhD, Lasse H. Jakobsen, Henrik Frederiksen, MD PhD, Mats Jerkeman, Alexander Fosså, MD PhD, Therese M.L. Andersson, PhD, Harald Holte, Jr., MD PhD, Martin Bøgsted, Professor, Tarec C. El-Galaly, Karin Ekstroem Smedby, MDPhD

Blood (2018) 132 (Supplement 1): 930.

https://doi.org/10.1182/blood-2018-99-111759

Published: 2018

Journal Articles

Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

Sara Harrysson, MD, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, Sverker Hasselblom, Björn E Wahlin, Per-Ola Andersson, Karin E Smedby

Blood (2018) 132 (Supplement 1): 2975.

https://doi.org/10.1182/blood-2018-99-110672

Published: 2018

Journal Articles

Prognostic Implications of Specific Comorbidities in Mantle Cell Lymphoma Patients, a Swedish Lymphoma Registry Study

Ingrid Glimelius, MD PhD, Karin Ekstroem Smedby, MD PhD, Mats Jerkeman, Sandra Eloranta, Caroline Weibull

Blood (2018) 132 (Supplement 1): 2891.

https://doi.org/10.1182/blood-2018-99-111471

Published: 2018

Journal Articles

Risk and Cause of Death in 9,563 Patients Diagnosed with Myeloproliferative Neoplasms in Sweden Between 1973 and 2005,

Malin L Hultcrantz, MD, Sally R Hinchliffe, Biostatistician, Sigurdur Y Kristinsson, M.D., Ph.D., Therese M-L Andersson, Biostatistician, Sandra Eloranta, Statistician, Åsa Rangert Derolf, MD, PhD, Jan Samuelsson, MD, PhD, Ola Landgren, MD, PhD, Paul W Dickman, Biostatistician, Paul Lambert, Biostatistician, Magnus Björkholm, MD, PhD

Blood (2011) 118 (21): 3855.

https://doi.org/10.1182/blood.V118.21.3855.3855

Published: 2011

Journal Articles

Patterns of Survival and Causes of Death In 9,384 Patients with Myeloproliferative Neoplasms Diagnosed In Sweden Between 1973 and 2008

Malin Hultcrantz, Sigurdur Y. Kristinsson, MD, PhD, Therese M-L Andersson, Sandra Eloranta, Åsa Rangert Derolf, Ola Landgren, M.D., Ph.D., Paul W Dickman, Magnus Bjorkholm

Blood (2010) 116 (21): 3071.

https://doi.org/10.1182/blood.V116.21.3071.3071

Published: 2010

Journal Articles

The Success Story of Targeted Therapy In Chronic Myeloid Leukemia: A Population-Based Study of 3,173 Patients Diagnosed In Sweden 1973–2008

Magnus Bjorkholm, MD, PhD, Lotta Ohm, MD, Sandra Eloranta, Statistician, Åsa Rangert Derolf, MD, PhD, Malin Hultcrantz, MD, Jan Sjöberg, MD, PhD, Therese Andersson, Biostatistician, Martin Hoglund, MD, PhD, Johan Richter, MD, PhD, Ola Landgren, MD, Ph, D, Sigurdur Y. Kristinsson, MD, PhD, Paul W. Dickman, Biostatistician

Blood (2010) 116 (21): 205.

https://doi.org/10.1182/blood.V116.21.205.205

Published: 2010

Journal Articles

Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study.

Åsa Rangert Derolf, M.D., Therese M-L Andersson, Paul C Lambert, Sigurdur Y Kristinsson, M.D., PhD., Sandra Eloranta, Ola Landgren, M.D., Ph.D., Paul W Dickman, Magnus Bjorkholm, MD, PhD

Blood (2009) 114 (22): 1378.

https://doi.org/10.1182/blood.V114.22.1378.1378

Published: 2009

NARROW

Temporal Trends in Relative Survival of Diffuse Large B-Cell Lymphoma in Sweden and Denmark in the Era of Targeted and Cellular Therapies: A Population-Based Binational Study

Age-Based Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI) in a Real-World Danish Study: Suboptimal Performance in Older Patients

Reproduktiv Patterns Among Non-Hodgkin Lymphoma Survivors By Subtype in Sweden, Denmark and Norway

Treatment-Related Circulatory Diseases and Mortality in Hodgkin Lymphoma Patients Using Multi-State Modelling and Relative Survival

Risk of Incident Diabetes and Dysregulated Pre-Existing Diabetes Mellitus in Newly Diagnosed Lymphoma Patients Treated with Steroid-Containing Immunochemotherapy: A Danish Population-Based Study

High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients

Evaluation of Eligibility for CAR-T Cell Therapy in a Population-Based Cohort of 3550 Patients with Incident Diffuse Large B-Cell Lymphoma (DLBCL) in Sweden

Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden

Autologous Stem Cell Transplantation in Mantle Cell Lymphoma - Selection Mechanisms and Survival By Age Group

Treatment Intensity, Timing of Relapse and Outcome of 713 Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Setting in Sweden

Fertility Rates in Young Hodgkin Lymphoma Survivors: A Danish Nationwide Cohort Study of 769 Patients

Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Relapse Risk and Loss in Expectation of Lifetime in Young Classical Hodgkin Lymphoma Patients - a Nordic Lymphoma Group Study of 2,582 Patients

Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

Prognostic Implications of Specific Comorbidities in Mantle Cell Lymphoma Patients, a Swedish Lymphoma Registry Study

Risk and Cause of Death in 9,563 Patients Diagnosed with Myeloproliferative Neoplasms in Sweden Between 1973 and 2005,

Patterns of Survival and Causes of Death In 9,384 Patients with Myeloproliferative Neoplasms Diagnosed In Sweden Between 1973 and 2008

The Success Story of Targeted Therapy In Chronic Myeloid Leukemia: A Population-Based Study of 3,173 Patients Diagnosed In Sweden 1973–2008

Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only